Sympathetic nervous system regulation of the tumour microenvironment.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 26299593.
- Also identified by DOI 10.1038/nrc3978 and PMC identifier 4828959.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The peripheral autonomic nervous system (ANS) is known to regulate gene expression in primary tumours and their surrounding microenvironment. Activation of the sympathetic division of the ANS in particular modulates gene expression programmes that promote metastasis of solid tumours by stimulating macrophage infiltration, inflammation, angiogenesis, epithelial-mesenchymal transition and tumour invasion, and by inhibiting cellular immune responses and programmed cell death. Haematological cancers are modulated by sympathetic nervous system (SNS) regulation of stem cell biology and haematopoietic differentiation programmes. In addition to identifying a molecular basis for physiologic stress effects on cancer, these findings have also identified new pharmacological strategies to inhibit cancer progression in vivo.
Medical subject headings
- Gene Expression Regulation, Neoplastic
- Sympathetic Nervous System
- Tumor Microenvironment